Literature DB >> 25183430

The LRIG family: enigmatic regulators of growth factor receptor signaling.

Catalina Simion1, Maria Elvira Cedano-Prieto1, Colleen Sweeney2.   

Abstract

The leucine-rich repeats and immunoglobulin-like domains (LRIG) family of transmembrane proteins contains three vertebrate members (LRIG1, LRIG2 and LRIG3) and one member each in flies (Lambik) and worms (Sma-10). LRIGs have stepped into the spotlight as essential regulators of growth factor receptors, including receptor tyrosine and serine/threonine kinases. LRIGs have been found to both negatively (LRIG1 and LRIG3) and positively (Sma-10 and LRIG3) regulate growth factor receptor expression and signaling, although the precise molecular mechanisms by which LRIGs function are not yet understood. The most is known about LRIG1, which was recently demonstrated to be a tumor suppressor. Indeed, in vivo experiments reinforce the essential link between LRIG1 and repression of its targets for tissue homeostasis. LRIG1 has also been identified as a stem cell marker and regulator of stem cell quiescence in a variety of tissues, discussed within. Comparably, less is known about LRIG2 and LRIG3, although studies to date suggest that their functions are largely distinct from that of LRIG1 and that they likely do not serve as growth/tumor suppressors. Finally, the translational applications of expressing soluble forms of LRIG1 in LRIG1-deficient tumors are being explored and hold tremendous promise.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  LRIG1; LRIG2; LRIG3; growth factor receptor; stem cell; tumor suppressor

Mesh:

Substances:

Year:  2014        PMID: 25183430      PMCID: PMC4182143          DOI: 10.1530/ERC-14-0179

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  81 in total

1.  Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells.

Authors:  S Kao ; R K Jaiswal; W Kolch; G E Landreth
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

2.  LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.

Authors:  David L Shattuck; Jamie K Miller; Melanie Laederich; Melanie Funes; Heidi Petersen; Kermit L Carraway; Colleen Sweeney
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

3.  LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling.

Authors:  Longchuan Bai; Donna McEachern; Chao-Yie Yang; Jianfeng Lu; Haiying Sun; Shaomeng Wang
Journal:  Cancer Res       Date:  2012-01-12       Impact factor: 12.701

4.  Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways.

Authors:  Hui Zhao; Kosuke Tanegashima; Hyunju Ro; Igor B Dawid
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

5.  E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases.

Authors:  Xiaolan Qian; Tatiana Karpova; Allan M Sheppard; James McNally; Douglas R Lowy
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

6.  Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF.

Authors:  Fernanda Ledda; Oliver Bieraugel; Shahrzad Shirazi Fard; Marçal Vilar; Gustavo Paratcha
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

7.  LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII.

Authors:  M A Stutz; D L Shattuck; M B Laederich; K L Carraway; C Sweeney
Journal:  Oncogene       Date:  2008-06-09       Impact factor: 9.867

8.  Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis.

Authors:  Yan Zhou; Shiuh-Ming Luoh; Yan Zhang; Colin Watanabe; Thomas D Wu; Michael Ostland; William I Wood; Zemin Zhang
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling.

Authors:  Vivian W Y Wong; Daniel E Stange; Mahalia E Page; Simon Buczacki; Agnieszka Wabik; Satoshi Itami; Marc van de Wetering; Richard Poulsom; Nicholas A Wright; Matthew W B Trotter; Fiona M Watt; Doug J Winton; Hans Clevers; Kim B Jensen
Journal:  Nat Cell Biol       Date:  2012-03-04       Impact factor: 28.824

10.  Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.

Authors:  Lei Chang; Runlin Shi; Tao Yang; Fan Li; Guohao Li; Yonglian Guo; Bin Lang; Weimin Yang; Qianyuan Zhuang; Hua Xu
Journal:  J Exp Clin Cancer Res       Date:  2013-12-08
View more
  24 in total

1.  Functional and evolutionary insights from the Ciona notochord transcriptome.

Authors:  Wendy M Reeves; Yuye Wu; Matthew J Harder; Michael T Veeman
Journal:  Development       Date:  2017-09-15       Impact factor: 6.868

2.  The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.

Authors:  Wenqi Chen; Jinhai Zhang; Huijuan Xu; Jie Dai; Xiaorong Zhang
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

3.  Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.

Authors:  Elizabeth A Marcus; Elmira Tokhtaeva; Shahlo Turdikulova; Joseph Capri; Julian P Whitelegge; David R Scott; George Sachs; Fedor Berditchevski; Olga Vagin
Journal:  Biochem J       Date:  2016-04-05       Impact factor: 3.857

4.  Identification of TOR-responsive slow-cycling neoblasts in planarians.

Authors:  Alyssa M Molinaro; Nicole Lindsay-Mosher; Bret J Pearson
Journal:  EMBO Rep       Date:  2021-01-28       Impact factor: 8.807

Review 5.  Assembly of Neuronal Connectivity by Neurotrophic Factors and Leucine-Rich Repeat Proteins.

Authors:  Fernanda Ledda; Gustavo Paratcha
Journal:  Front Cell Neurosci       Date:  2016-08-09       Impact factor: 5.505

6.  Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells.

Authors:  Keiko Maeda; Atsushi Enomoto; Akitoshi Hara; Naoya Asai; Takeshi Kobayashi; Asuka Horinouchi; Shoichi Maruyama; Yuichi Ishikawa; Takahiro Nishiyama; Hitoshi Kiyoi; Takuya Kato; Kenju Ando; Liang Weng; Shinji Mii; Masato Asai; Yasuyuki Mizutani; Osamu Watanabe; Yoshiki Hirooka; Hidemi Goto; Masahide Takahashi
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

7.  Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.

Authors:  Cecilia Ranhem; Gabriella Lillsunde Larsson; Håkan Hedman; David Lindquist; Mats G Karlsson; Ann-Cathrin Hellström; Ellinor Östensson; Bengt Sorbe; Kristina Hellman; Sonia Andersson
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

8.  C. elegans SMA-10 regulates BMP receptor trafficking.

Authors:  Ryan J Gleason; Mehul Vora; Ying Li; Nanci S Kane; Kelvin Liao; Richard W Padgett
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

9.  Notch1 targeted regulation of mir-224/LRIG2 signaling for the proliferation and apoptosis of cervical cancer cells.

Authors:  Lanxiang Cong; Fang Zhang; Huaihai Shang
Journal:  Oncol Lett       Date:  2017-02-03       Impact factor: 2.967

Review 10.  From gene discovery to new biological mechanisms: heparanases and congenital urinary bladder disease.

Authors:  Neil A Roberts; Emma N Hilton; Adrian S Woolf
Journal:  Nephrol Dial Transplant       Date:  2015-08-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.